TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
INVESTING

It's True, Small-Cap Biotech Stocks Are Acting Badly These Days

  • By Adam Feuerstein
  • Oct 7, 2014 11:39 AM EDT
Why Ambit Biosciences (AMBI) Stock Is Soaring Today
MARKETS

Why Ambit Biosciences (AMBI) Stock Is Soaring Today

  • By Andrew Meola
  • Sep 29, 2014 2:38 PM EDT
Analysts' Actions: AMZN TWC TWTR YELP YHOO
STOCKS

Analysts' Actions: C.R. Bard, Gap, GNC, Medtronic, Tyson Foods

  • By TheStreet Staff
  • Jun 18, 2014 8:16 AM EDT
5 Hated Earnings Stocks You Should Love
INVESTING

3 Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • Dec 13, 2013 9:30 AM EST
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Biotech Stock Bubble Debate in 14 Charts

  • By Adam Feuerstein
  • Oct 23, 2013 7:06 AM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS

Biotech Stock Mailbag: Sarepta, Chelsea, IPO Fever

  • By Adam Feuerstein
  • Jul 19, 2013 6:00 AM EDT
Top Insider Trades: AYR IVH PTGI REED
STOCKS

Top Insider Trades: RH, AMBI, LULU, CYCC

  • By Jonathan Moreland
  • May 23, 2013 9:17 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.